2 suspended. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz WP1302, WP1302 placebo, methimazole - Graves Disease | Phase 2 | Suspended | Worg Biotherapeutics Inc. | 176 | 2026-03-31 | 2025-05-08 |
| UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone Lenvatinib, Everolimus - Thyroid Cancer | Phase 2 | Suspended | Thomas Jefferson University | 5 | 2017-04-03 | 2021-10-15 |
Graves Disease (1) · Thyroid Neoplasms (1)
Endocrine System Diseases (2) · Autoimmune Diseases (1) · Endocrine Gland Neoplasms (1) · Exophthalmos (1) · Eye Diseases (1) · Goiter (1) · Head and Neck Neoplasms (1) · Hyperthyroidism (1) · Immune System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Orbital Diseases (1)
Everolimus (1) · Methimazole (1) · lenvatinib (1)
Thomas Jefferson University (1) · Worg Biotherapeutics Inc. (1)
United States (2)
Dylan Lee, MD (1) · Marcia Brose, MD, PhD (1)